Health
Drug Development Weight Loss Drugs Drug Safety Weight Loss Clinical Trials Drug Pricing Drug Approval Vaccines Prescription Drugs Drug Manufacturing
Securing Ohtuvayre for chronic obstructive pulmonary disease bolsters Merck’s respiratory portfolio in preparation for Keytruda’s patent expiry.